Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 Jan;78(1):19–23. doi: 10.1136/bjo.78.1.19

Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results.

G Modorati 1, R Brancato 1, G Paganelli 1, P Magnani 1, R Pavoni 1, F Fazio 1
PMCID: PMC504684  PMID: 8110692

Abstract

Several problems still limit the full use of the diagnostic potential of immunoscintigraphy (IS) with technetium-99m labelled monoclonal antibodies (MoAbs) 225-28S directed to high molecular weight melanoma associated antigen (HMW-MAA). The principal problem is the unfavourable ratio of tumour to non-tumour activity (T/nT), due to the poor tumour uptake and the high aspecific uptake of the tissue surrounding the tumour. Recently, it was demonstrated that using the tumour pretargeting technique based on the injection of monoclonal antibody and the avidin/biotin system (three step immunoscintigraphy), an improvement in the T/nT ratio can be obtained in patients with carcinoembryonic antigen secreting tumours. The aim of this study was to compare the diagnostic sensitivity of traditional immunoscintigraphy with that of three step immunoscintigraphy in seven patients with uveal melanoma. All the patients underwent immunoscintigraphy with MoAb 225.28S radiolabelled with technetium-99m, and a three step immunoscintigraphy 1 week later. No patients demonstrated immediate toxic effects after receiving the reagents, no matter which of the two methods was used. The traditional immunoscintigraphy had a diagnostic sensitivity of 71.4%, diagnosing five out of seven melanomas tested. The three step study detected all the melanomas examined (7/7) with a diagnostic sensitivity of 100% and showed a drastic reduction in background. The preliminary results confirm the feasibility of visualising the uveal melanoma and show that the three step immunoscintigraphy is more diagnostically sensitive than traditional immunoscintigraphy, particularly in small lesions.

Full text

PDF
19

Images in this article

21Image
on p.21
21Image
on p.21

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bomanji J., Garner A., Prasad J., Albert D. M., Hungerford J. L., Granowska M., Britton K. E. Characterisation of ocular melanoma with cutaneous melanoma antibodies. Br J Ophthalmol. 1987 Sep;71(9):647–650. doi: 10.1136/bjo.71.9.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bomanji J., Hungerford J. L., Granowska M., Britton K. E. Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments. Br J Ophthalmol. 1987 Sep;71(9):651–658. doi: 10.1136/bjo.71.9.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bomanji J., Hungerford J. L., Granowska M., Britton K. E. Uptake of 99mTc labelled (Fab')2 fragments of monoclonal antibody 225.28S by a benign ocular naevus. Eur J Nucl Med. 1988;14(3):165–166. doi: 10.1007/BF00293543. [DOI] [PubMed] [Google Scholar]
  4. Bomanji J., Nimmon C. C., Hungerford J. L., Solanki K., Granowska M., Britton K. E. Ocular radioimmunoscintigraphy: sensitivity and practical considerations. J Nucl Med. 1988 Jun;29(6):1031–1037. [PubMed] [Google Scholar]
  5. Damato B. E., Campbell A. M., McGuire B. J., Lee W. R., Foulds W. S. Monoclonal antibodies to human primary uveal melanomas demonstrate tumor heterogeneity. Invest Ophthalmol Vis Sci. 1986 Sep;27(9):1362–1367. [PubMed] [Google Scholar]
  6. Lucignani G., Paganelli G., Modorati G., Pieralli S., Rizzo G., Magnani P., Colombo F., Zito F., Landoni C., Scotti G. MRI, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma. J Comput Assist Tomogr. 1992 Jan-Feb;16(1):77–83. doi: 10.1097/00004728-199201000-00014. [DOI] [PubMed] [Google Scholar]
  7. Natali P. G., Bigotti A., Nicotra M. R., Nardi R. M., Delovu A., Segatto O., Ferrone S. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies. Cancer Res. 1989 Mar 1;49(5):1269–1274. [PubMed] [Google Scholar]
  8. Paganelli G., Magnani P., Zito F., Villa E., Sudati F., Lopalco L., Rossetti C., Malcovati M., Chiolerio F., Seccamani E. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res. 1991 Nov 1;51(21):5960–5966. [PubMed] [Google Scholar]
  9. Paganelli G., Malcovati M., Fazio F. Monoclonal antibody pretargetting techniques for tumour localization: the avidin-biotin system. International Workshop on Techniques for Amplification of Tumour Targetting. Nucl Med Commun. 1991 Mar;12(3):211–234. doi: 10.1097/00006231-199103000-00006. [DOI] [PubMed] [Google Scholar]
  10. Paganelli G., Pervez S., Siccardi A. G., Rowlinson G., Deleide G., Chiolerio F., Malcovati M., Scassellati G. A., Epenetos A. A. Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies. Int J Cancer. 1990 Jun 15;45(6):1184–1189. doi: 10.1002/ijc.2910450632. [DOI] [PubMed] [Google Scholar]
  11. Schaling D. F., van Kroonenburgh M. J., Borsje R. A., Camps J. A., Kakebeeke-Kemme H. M., Oosterhuis J. A., Pauwels E. K. Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 1989;227(3):291–294. doi: 10.1007/BF02172765. [DOI] [PubMed] [Google Scholar]
  12. Schaling D. F., van der Pol J. P., Jager M. J., van Kroonenburgh M. J., Oosterhuis J. A., Ruiter D. J. Radioimmunoscintigraphy and immunohistochemistry with melanoma-associated monoclonal antibodies in choroidal melanoma: a comparison of the clinical and immunohistochemical results. Br J Ophthalmol. 1990 Sep;74(9):538–541. doi: 10.1136/bjo.74.9.538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Scheidhauer K., Markl A., Leinsinger G., Moser E., Scheiffarth O. F., Riedel K. G., Schaal T. S., Stefani F. H., Schumacher U. Immunoscintigraphy in intraocular malignant melanoma. Nucl Med Commun. 1988 Sep;9(9):669–678. doi: 10.1097/00006231-198809000-00010. [DOI] [PubMed] [Google Scholar]
  14. Scheidler J., Leinsinger G., Kirsch C. M., Scheiffarth O. F., Stefani F. H., Riedel K. G. Immunoimaging of choroidal melanoma: assessment of its diagnostic accuracy and limitations in 101 cases. Br J Ophthalmol. 1992 Aug;76(8):457–460. doi: 10.1136/bjo.76.8.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Seccamani E., Tattanelli M., Mariani M., Spranzi E., Scassellati G. A., Siccardi A. G. A simple qualitative determination of human antibodies to murine immunoglobulins (HAMA) in serum samples. Int J Rad Appl Instrum B. 1989;16(2):167–170. doi: 10.1016/0883-2897(89)90191-8. [DOI] [PubMed] [Google Scholar]
  16. Siccardi A. G., Buraggi G. L., Natali P. G., Scassellati G. A., Viale G., Ferrone S. European multicentre study on melanoma immunoscintigraphy by means of 99mTc-labelled monoclonal antibody fragments. The European Multicentre Study Group. Eur J Nucl Med. 1990;16(4-6):317–323. doi: 10.1007/BF00842787. [DOI] [PubMed] [Google Scholar]
  17. van der Pol J. P., Jager M. J., de Wolff-Rouendaal D., Ringens P. J., Vennegoor C., Ruiter D. J. Heterogeneous expression of melanoma-associated antigens in uveal melanomas. Curr Eye Res. 1987 Jun;6(6):757–765. doi: 10.3109/02713688709034842. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES